NASDAQ
No price data available for this timeframe.
AbbVie Inc. (ABBV) has a consensus Buy rating from 41 analysts with an average price target of $258.00, representing +2.6% upside from the current price of $251.52.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| Jun 23, 2026 | Unknown | Canaccord Genuity | $273.00 | $230.06 | +18.66% |
| Jun 22, 2026 | Unknown | Wells Fargo | $260.00 | $216.63 | +20.02% |
| May 15, 2026 | Unknown | Evercore ISI | $235.00 | $212.04 | +10.83% |
| May 14, 2026 | Unknown | Piper Sandler | $298.00 | $208.50 |
Jun 23, 2026 | Maintained | Canaccord Genuity | Buy | Buy |
Jun 23, 2026 | Maintained | Piper Sandler | Overweight | Overweight |
May 15, 2026 | Maintained | Evercore ISI Group | Outperform | Outperform |
May 14, 2026 | Maintained | Piper Sandler | Overweight | Overweight |
May 4, 2026 | Maintained | Evercore ISI Group | Outperform | Outperform |
| +42.93% |
| Apr 30, 2026 | Unknown | Morgan Stanley | $278.00 | $212.15 | +31.04% |